Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation (NCT06719232) | Clinical Trial Compass
RecruitingNot Applicable
Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation
Hungary300 participantsStarted 2024-10-01
Plain-language summary
This study aims to evaluate a catheter-free method for delivering medications directly into the bladder, known as intravesical instillation, which is commonly used to treat conditions such as interstitial cystitis/bladder pain syndrome (IC/BPS), recurrent urinary tract infections, bladder cancer, and post-chemotherapy or post-radiation cystitis.
The study investigates whether this method, which eliminates the need for catheterization, reduces discomfort and complications while maintaining treatment effectiveness. By collecting data on patient experiences and outcomes, the study seeks to determine if this approach provides a safer and more comfortable alternative to traditional catheter-based treatments.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male and female patients aged between 18 and 80 years.
* Patients for whom the treating physician has determined that intravesical instillation is necessary due to one of the following conditions:
* Interstitial cystitis/bladder pain syndrome (IC/BPS).
* Recurrent urinary tract infections (UTIs).
* Non-muscle invasive bladder cancer.
* Post-radiation cystitis.
* Post-chemotherapy cystitis.
* Negative urine culture within the last two weeks.
* Patients who provide verbal and written informed consent to participate in the study.
Exclusion Criteria:
* Urinary tract infection within the past month or currently active infection.
* Diagnosed bleeding disorders or recurrent macroscopic hematuria.
* Post-void residual urine volume greater than 100 ml.
* Mental condition that prevents reliable cooperation.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Patient Discomfort During Catheter-Free Intravesical Instillation